Listed

ImmunityBio, Inc.

IBRXNasdaqCIK 1326110HealthcareFiscal year ends Dec 31

Reports and events: 180 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

ImmunityBio, Inc., Reports and events
FiledFormWhat it isAccession number
2021-06-1117:18 ET8-K2.02 Results of operations; 5.07 Shareholder vote results0001193125-21-189023
2021-06-0408:30 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-21-182190
2021-05-2816:08 ET8-K1.01 Entry into a material agreement0001193125-21-176935
2021-05-1416:06 ET10-QQuarterly reportPeriod 2021-03-310001564590-21-028010
2021-05-0306:06 ET8-K1.01 Entry into a material agreement; 2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-21-146472
2021-04-2916:31 ETDEF 14AProxy statementPeriod 2021-06-100001193125-21-140564
2021-04-2216:06 ET8-K/A8.01 Other events; 9.01 Financial statements and exhibits0001193125-21-126681
2021-04-0109:15 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001193125-21-103380
2021-03-1717:24 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-21-084244
2021-03-1214:59 ETSC 13D/AOwnership report, active investor, amended0001193125-21-079404
2021-03-1021:58 ET8-K2.01 Completion of an acquisition or disposition; 2.03 New direct financial obligation; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-21-075243
2021-03-0416:11 ET10-KAnnual reportPeriod 2020-12-310001564590-21-010945
2021-02-2517:15 ET8-K8.01 Other events0001193125-21-057184
2021-02-2416:59 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-21-054808
2021-02-1016:38 ET8-K5.02 Departure or appointment of officers or directors0001193125-21-036358
2021-01-1309:17 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-21-007807
2020-12-2206:07 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001193125-20-323766
2020-12-2110:58 ETSC 13D/AOwnership report, active investor, amended0001193125-20-322658
2020-12-2107:23 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-20-322298
2020-11-0916:06 ET10-QQuarterly reportPeriod 2020-09-300001564590-20-052488
2020-10-2617:05 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001193125-20-277062
2020-08-2416:10 ET8-K1.01 Entry into a material agreement0001193125-20-228341
2020-08-0709:01 ET10-QQuarterly reportPeriod 2020-06-300001564590-20-038096
2020-06-2919:09 ETSC 13D/AOwnership report, active investor, amended0001193125-20-182706
2020-06-2516:28 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-20-179095
2020-06-2417:26 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-20-177788
2020-06-1916:33 ET8-K5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001193125-20-174073
2020-06-1218:25 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results0001193125-20-166829
2020-05-2716:10 ET8-K1.01 Entry into a material agreement0001193125-20-153068
2020-05-1116:06 ET10-QQuarterly reportPeriod 2020-03-310001564590-20-024168
2020-04-2416:02 ETDEF 14AProxy statementPeriod 2020-06-100001193125-20-119033
2020-03-2516:09 ET10-KAnnual reportPeriod 2019-12-310001564590-20-012816
2019-11-0516:06 ET10-QQuarterly reportPeriod 2019-09-300001564590-19-040363
2019-08-0716:05 ET8-K5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001193125-19-215311
2019-08-0616:07 ET10-QQuarterly reportPeriod 2019-06-300001564590-19-029330
2019-06-1016:04 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-19-169172
2019-06-0716:05 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001193125-19-168170
2019-05-0816:06 ET10-QQuarterly reportPeriod 2019-03-310001564590-19-017179
2019-04-2616:06 ETDEF 14AProxy statementPeriod 2019-06-060001193125-19-122311
2019-04-0116:06 ETSC 13D/AOwnership report, active investor, amended0001193125-19-094504
2019-03-1316:07 ET10-KAnnual reportPeriod 2018-12-310001564590-19-007562
2018-11-0716:08 ET10-QQuarterly reportPeriod 2018-09-300001564590-18-028007
2018-08-0616:06 ET10-QQuarterly reportPeriod 2018-06-300001564590-18-019420
2018-06-1316:07 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results0001193125-18-191630
2018-05-0716:06 ET10-QQuarterly reportPeriod 2018-03-310001564590-18-011240
2018-04-2416:05 ETDEF 14AProxy statementPeriod 2018-06-070001193125-18-128761
2018-04-1716:45 ET8-K5.02 Departure or appointment of officers or directors0001193125-18-119869
2018-03-1216:07 ET10-KAnnual reportPeriod 2017-12-310001564590-18-005290
2017-11-0716:04 ET10-QQuarterly reportPeriod 2017-09-300001564590-17-022217
2017-09-2216:05 ET8-K5.02 Departure or appointment of officers or directors0001193125-17-291376

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 9, 2026, 17:45 ET. Listed shows no prices and gives no investment advice.